Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nalbuphine combined with propofol for sedation during painless gastroscopy
ChiCTR2000032583Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital of Xiamen University
- Start
- May 2020
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of nalbuphine and propofol (2 arms), sponsored by First Affiliated Hospital of Xiamen University. Primary endpoints: Blood pressure, Heart rate and 4 more. Planned start May 2020; status: not yet recruiting.
02
Drugs
nalbuphinepropofol
Beyond the preview
Go deeper on ChiCTR2000032583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000032583.